Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Clin Ther ; 11(3): 304-14, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2663160

RESUMO

The efficacy of cefonicid and of ceftriaxone, administered once daily for the treatment of lower respiratory tract bacterial infections (pneumonia or bronchitis), was evaluated and compared in 118 patients with chronic lung disease. The patients were randomly assigned to receive 1 gm of either drug, intravenously or intramuscularly, daily for three to 11 days (mean, seven days). Pathogenic bacteria were isolated from sputum in 59% of patients; Haemophilus influenzae and Streptococcus pneumoniae predominated. Clinical cure or improvement was noted in 95% and 93% of patients treated with cefonicid and ceftriaxone, respectively, and bacteriologic cure or improvement in 69% and 81% (the differences were not significant). Side effects were infrequent and similar in the two treatment groups, except that diarrhea was more common in the ceftriaxone group (11%, versus 4.4% in the cefonicid group). It is concluded that patients with chronic lung disease who experience acute exacerbations associated with infection caused by H influenzae or S pneumoniae, or other susceptible organisms, can be effectively treated with once-daily administration of either cefonicid or ceftriaxone.


Assuntos
Cefalosporinas/uso terapêutico , Pneumopatias Obstrutivas/complicações , Infecções Respiratórias/tratamento farmacológico , Adulto , Idoso , Bronquite/tratamento farmacológico , Bronquite/microbiologia , Cefamandol/análogos & derivados , Cefamandol/uso terapêutico , Cefonicida , Ceftriaxona/uso terapêutico , Cefalosporinas/administração & dosagem , Ensaios Clínicos como Assunto , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pneumonia/tratamento farmacológico , Pneumonia/microbiologia , Estudos Prospectivos , Distribuição Aleatória , Infecções Respiratórias/microbiologia
2.
Pediatrics ; 63(1): 13-7, 1979 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-440789

RESUMO

The carotid bodies of four infants who died of sudden infant death syndrome (SIDS) were compared, using electron microscopic techniques, with the carotid bodies of various control subjects. In the SIDS patients, there was a marked reduction or absence of the dense cytoplasmic granules of the carotid chemorecptor cells, as well as a reduction in cell number and size. These ultrastructural abnormalities may be pathophysiologically related to SIDS. A defect in this respiratory control organ could block normal stimulation of respiration during the periods of hypoxia that occur during episodes of sleep apnea in infancy. Further studies by electron microscopy are required to confirm degranulation of the carotid body as a pathognomonic sign of SIDS. Screening of high-risk infants should be directed at studying the carotid body and its mediated responses to hypoxia.


Assuntos
Corpo Carotídeo/patologia , Morte Súbita do Lactente/patologia , Corpo Carotídeo/ultraestrutura , Humanos , Lactente , Recém-Nascido , Microscopia Eletrônica
3.
Am Rev Respir Dis ; 113(5): 683-8, 1976 May.
Artigo em Inglês | MEDLINE | ID: mdl-178258

RESUMO

A case of influenza pneumonia is described in which death occurred from persistence of the influenza infection and suprainfection with two bacteria, Staphylococcus aureus and Escherichia coli, and another virus, Herpes simplex. Of additional interest were the observations that this overwhelming illness developed in a previously healthy person, that typical influenza virus particles were present in antemortem lung tissue, and that the patient died despite 6 days of extracorporeal membrane oxygenation and corticosteroids.


Assuntos
Infecções por Escherichia coli/complicações , Infecções por Herpesviridae/complicações , Herpesviridae , Influenza Humana/complicações , Pneumonia Estafilocócica/complicações , Pneumonia Viral/complicações , Adulto , Escherichia coli/isolamento & purificação , Herpesviridae/isolamento & purificação , Humanos , Influenza Humana/mortalidade , Influenza Humana/patologia , Pulmão/patologia , Masculino , Pneumonia/microbiologia , Pneumonia/mortalidade , Pneumonia/patologia , Staphylococcus aureus/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA